• 1. Physical Examination Center, West China Hospital, Sichuan University, Chengdu 610041, China; 2. Department of Orthopedic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China;3. Department of Central Transportation, West China Hospital, Sichuan University, Chengdu 610041, China;
LI Li, Email: ganjun@umich.edu
Export PDF Favorites Scan Get Citation

Objective  To evaluate the effectiveness of hormone replacement therapy (HRT) for osteoporosis in postmenopausal women.
Method  Systematic reviews and meta-analyses were searched in Cochrane Library (Issue 4, 2008), MEDLINE (1978-2008) and Clinical Evidence database. Search terms included Postmenopausal (post-menopausal) osteoporosis, therapy, vertebral fracture, hormone replacement therapy, randomized controlled trial, meta analysis, female,human.
Result  A total of 4 protocols were found in Cochrane Library and a meta-analyse was found in MEDLINE. The result demonstrated that both cancellous and cortical bone mineral density increased after HRT. Statistically significant reductions in the risk of vertebral and non-vertebral fracture were also found.
Conclusion  HRT can reduce the risk of osteoporotic fracture by increasing bone density. However, other disease and adverse event were also associated with the BMD increase. Therefore, both advantage and disadvantage should be considered before applying HRT therapy to postmenopausal osteoporosis patients.

Citation: LI Li,FENG Ganjun,WEI Yi. Clinical Evidence of the Hormone Replacement Therapy for Osteoporosis. Chinese Journal of Evidence-Based Medicine, 2010, 10(9): 1125-1126. doi: 10.7507/1672-2531.20100555 Copy

  • Previous Article

    Evidence-Based Treatment for a Newly Diagnosed Open-Angle Glaucoma Patient